Variation analysis of HPV16 cell-type-specific enhancer in cervical carcinoma
- Author:
Wenkang LIU
1
Author Information
1. Department of Immunology and Pathogenbiology
- Publication Type:Journal Article
- From:Academic Journal of Xi'an Jiaotong University
2006;18(2):171-173
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the cell-type-specific enhancer (CTSE) in HPV16 and its variation in cervical carcinoma. Methods: CTSEs were detected by polymerase chain reaction (PCR) in 58 cervical carcinoma from Shaanxi province; in addition variation of CTSEs was analyzed through single-strand conformation polymorphisms (SSCP). Results: HPV16 CTSEs were detectable in 34 of 58 (57%) specimens and mutant rate was 41% (14/34) and the main mutations of chosen randomly variant CTSE (CTSEv) happened at YY1 binding sites in addition to glucocoticoid response elements (GRE). Conclusion: CTSE in some specimens of Shaanxi province was obviously different from that in HPV16 wild type and variant CTSE might affect the transcriptional regulation of LCR on viral P97, which regulates over-expression of viral oncogenes in cervical carcinoma.